Last reviewed · How we verify

Vitamin A + Zinc

National Institute of Allergy and Infectious Diseases (NIAID) · FDA-approved active Small molecule

Vitamin A and zinc work synergistically to support immune function and mucosal barrier integrity, enhancing resistance to infections.

Vitamin A and zinc work synergistically to support immune function and mucosal barrier integrity, enhancing resistance to infections. Used for Reduction of infection morbidity and mortality in children with vitamin A and zinc deficiency, Immune support in resource-limited settings with high infectious disease burden.

At a glance

Generic nameVitamin A + Zinc
SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Drug classMicronutrient supplement combination
ModalitySmall molecule
Therapeutic areaImmunology / Infectious Disease
PhaseFDA-approved

Mechanism of action

Vitamin A (retinol) is essential for maintaining epithelial cell differentiation and immune cell development, particularly T cells and antibody-producing B cells. Zinc is a critical cofactor for numerous immune enzymes and proteins, supporting both innate and adaptive immunity. Together, these micronutrients enhance immune response and reduce infection risk, particularly in populations with deficiency.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: